Furthermore, these studies suggest that immune modulation with medications such as anti-IgE, anti-IL-4, and/or IL-13 monoclonal antibodies may be helpful in the treatment of ABPA. The gene discussed is IGHE; the disease is allergic bronchopulmonary aspergillosis.